Sequenta (MLC Dx) closes $13 million in Series B financing - MarketLine Financial Deals

Sequenta (MLC Dx) closes $13 million in Series B financing

Sequenta (MLC Dx) closes $13 million in Series B financing - MarketLine Financial Deals
Sequenta (MLC Dx) closes $13 million in Series B financing
Published Dec 08, 2010
3 pages — Published Dec 08, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Sequenta, Inc. (formerly MLC Dx, Inc.), a US-based developer and commercialization of molecular diagnostics assays, has secured $13 million in Series B financing.

  
Source:
Document ID
MA41788_101210
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Sequenta (MLC Dx) closes $13 million in Series B financing" Dec 08, 2010. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Sequenta-MLC-Dx-closes-13-million-in-Series-B-financing-2052-48608>
  
APA:
MarketLine Financial Deals. (2010). Sequenta (MLC Dx) closes $13 million in Series B financing Dec 08, 2010. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Sequenta-MLC-Dx-closes-13-million-in-Series-B-financing-2052-48608>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.